TrialVaccine2024

Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults.

Lisa A Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.